CK Hutchison Holdings Limited

0001.HK Q2 2026

Reported: 2026-08-15

CK Hutchison’s shares declined 1.7% after the earnings release as investors digested solid revenue and earnings growth tempered by a decline in operating free cash flow and a cautious outlook masked by timing and one-off effects.

Key takeaways

Underlying revenue grew 7%, driven in part by a 4% tailwind from favorable foreign exchange movements.
Pre-IFRS 16 net earnings increased by 6%, reflecting steady earnings growth across businesses.
Operating free cash flow declined year-over-year due to significant equity investments (HKD 3.7 billion) in associates and joint ventures, including Northumbrian Water, and timing differences with capital returns from TPG.
Consolidated net debt to total capital improved to 8.1%, expected to fall toward 2% following the completion of Vodafone interest sale.
EBITDA growth was robust but reflects similar positive foreign exchange impact; underlying segment mix and contributions remained broadly stable.

View recap

JD Logistics, Inc.

2618.HK Q2 2026

Reported: 2026-08-15

Shares of JDL fell sharply by 15.4% following the release of Q2 2026 results, as investors were likely disappointed by margin compression driven by operational adjustments and rising outsourcing costs, casting doubt on near-term profitability despite healthy revenue growth.

Key takeaways

Total revenue grew 24.3% year-over-year to RMB 64.10 billion, with external customer revenue up 30.8%.
Integrated supply chain revenue increased 12.1%, led by growth in JD Group fulfillment and external customer expansion.
Gross profit margin declined 0.9 percentage points year-over-year to 9.7%, weighed down by business adjustments at Deppon.
Outsourcing costs surged 40.5% to RMB 23.7 billion, increasing as a percentage of revenue by 4.3 points to 37%, reflecting consolidation and higher reliance on crowd-sourced delivery.
Non-IFRS net profit margin stood at 4.1%, with operating profit up 11.6% year-over-year, but margin pressures persisted amid cost volatility and margin headwinds.

View recap

CapitaLand Investment Limited

9CI.SI Q2 2026

Reported: 2026-08-15

CapitaLand Investments’ shares rose modestly by 1.1% post-earnings, reflecting a broadly stable reaction to a first half marked by fee income growth offsetting declines in the real estate investment segment. The market remained cautious, signaling mixed views on sustainability of the revenue shifts and underlying portfolio changes.

Key takeaways

Total revenue was flat, driven by a 20% increase in fee income primarily from private and listed funds, offset by a 24% decline in real estate investment revenue due mainly to divestments and deconsolidations.
Operating profit rose 13%, supported by the uplift in fee income, while real estate investment profits held steady aided by lower interest costs and some divestment gains.
Fee business growth was led by strong transaction activity in listed funds, including over $10 billion in transactions and multiple equity raisings, though this level of activity may not fully repeat in H2.
Private funds benefited notably from the previous acquisition of Wingate, with private credit now making a significant revenue contribution alongside other fund series showing higher returns.
Margins improved in commercial management, helped by operational efficiencies and better leasing performance, while lodging segment revenue rose about 4% excluding one-offs, with ongoing investments positioning it more for future growth than near-term profit.

View recap

Absci Corporation Common Stock

ABSI Q2 2026

Reported: 2026-08-15

Absci’s shares rose 5.4% following interim Phase I data that demonstrated favorable safety and pharmacokinetics for ABS-201, underpinning optimism around its potential dosing schedule and the strategic partnership with Eli Lilly.

Key takeaways

Interim Phase I data show ABS-201 was well tolerated with a favorable safety and immunogenicity profile.
Pharmacokinetic results estimate a half-life of at least 65 days, supporting a dosing regimen of 2 to 3 injections over six months.
Strategic $40 million investment from Eli Lilly strengthens collaboration and includes Lilly participation on Absci’s endometriosis advisory board.
Absci completed a $100 million financing round, enabling ongoing development and pipeline expansion.
The Atlas platform is actively generating novel target hypotheses, including new indications for the prolactin receptor franchise, reflecting progress in leveraging AI-driven discovery.

View recap

Applied Materials, Inc.

AMAT Q3 2026

Reported: 2026-08-15

Applied Materials' stock fell 7.5% following the quarter as investor enthusiasm was tempered by signs of margin pressure and a cautious outlook despite robust revenue growth driven by AI demand.

Key takeaways

Revenue growth remained strong, driven by rapid AI infrastructure buildout and leadership in advanced packaging, with packaging revenues expected to increase over 70% in calendar 2026.
Customers are providing longer-term commitments and rolling 8-quarter forecasts, improving demand visibility for fiscal 2027.
The company highlighted investments in AI-enabled R&D and operational efficiencies contributing to revenue and margin potential.
Despite the upbeat tone on demand, investors likely reacted negatively due to cautious outlook nuances and implied margin compression amid rapid capacity expansion and supply chain challenges.
Advanced services and process optimization offerings continue to gain traction, with over 37,000 chambers connected to AIx software capabilities supporting fab productivity.

View recap

Alpha and Omega Semiconductor Limited

AOSL Q4 2026

Reported: 2026-08-15

Shares dropped 12.1% as investors reacted negatively to cautious near-term guidance and significant expected sequential declines in the Consumer segment, signaling concerns over margin pressure and uneven demand across key markets despite pockets of strength.

Key takeaways

Q4 revenue was $170.4 million, down 3.5% year-over-year but up 4% sequentially; non-GAAP gross margin contracted to 23.7% with a non-GAAP loss per share of $0.13.
Advanced Computing showed strong momentum with a 35% sequential increase, currently representing 31% of Computing revenue and expected to grow over 40% next quarter, driven by AI and server platforms.
Consumer segment revenue fell 21.3% year-over-year but grew 8% sequentially; however, a sharp 25% sequential revenue decline is forecasted next quarter due to expected weakness across Gaming, Wearables, and Home Appliances.
Communications segment revenue rose 22.3% year-over-year but declined 2.3% sequentially; mixed outlook due to premium smartphone strength being offset by ongoing supply constraints and lower-tier softness.
Power Supply and Industrial segment grew modestly, up 1.4% year-over-year and 5.2% sequentially, with momentum in E-Mobility and AI-related DC fans partially offset by weakness in Quick Chargers and AC-DC power supplies.

View recap

Apotex Health Corp

APTX.TO Q1 2027

Reported: 2026-08-15

Apotex shares declined 4.0% following the quarter as investors reacted to cautious fiscal 2027 guidance coupled with deceleration in U.S. revenues and uncertainty around product launch timing, undermining growth expectations.

Key takeaways

Reported revenue grew approximately 2% year-over-year on a comparable basis, driven by 11% growth in Canada, notably from semaglutide demand and recent launches.
U.S. revenue represented 43% of sales but showed signs of deceleration due to halted production on the OPTHA 2 line and delayed FDA reinspection of new sterile manufacturing capacity.
Full-year guidance was introduced for upper mid-single-digit revenue growth excluding legacy product impacts, with adjusted EBITDA margin around 30%, reflecting a cautious outlook amid operational headwinds.
Product launch cadence remains critical, with timing risks highlighted by the absence of this year’s nilotinib launch compared to last year’s first-to-file, postponed to Q3.
Operational execution included $800 million debt reduction and ongoing productivity initiatives targeting over $100 million savings, but margin expansion appears constrained in the near term.

View recap

Atea Pharmaceuticals, Inc.

AVIR Q2 2026

Reported: 2026-08-15

Atea’s stock was largely unchanged, rising just 0.4% post-earnings, reflecting investor neutrality toward the phase 3 CBEYOND trial results, which met non-inferiority criteria but showed cure rates comparable, not superior, to the current standard of care.

Key takeaways

The CBEYOND Phase 3 trial met its primary and secondary endpoints, demonstrating bemrusasvir’s non-inferiority to Epclusa with SVR rates of 93.9% versus 94.8% (MITT population).
Bemrusasvir offers an 8-week regimen for non-cirrhotic patients versus 12 weeks for Epclusa, addressing the unmet need for shorter treatment duration.
Safety profiles were comparable with no serious adverse events attributed to bemrusasvir; three deaths occurred in the Epclusa arm but were unrelated to drug.
The second global Phase 3 trial is fully enrolled (~880 patients), with topline results expected in early Q1 2027.
Atea remains financially stable with $219.5M in cash and equivalents, supporting operations through 2027.

View recap

Birkenstock Holding plc

BIRK Q3 2026

Reported: 2026-08-15

Birkenstock's Q3 results beat expectations, driving a 7.1% stock gain as revenue growth hit the high end of guidance at 15% in constant currency, supported by strong DTC expansion and margin improvement despite elevated freight costs.

Key takeaways

Revenue grew 15% in constant currency, matching the company’s raised full-year guidance of 13% to 15%.
Adjusted EBITDA margin improved by 60 basis points year-over-year on a like-for-like basis, even with increased freight costs linked to geopolitical tensions.
DTC business expanded 16% in constant currency, with own retail revenue up 50% and same-store sales increasing high single digits.
Geographic momentum was broad-based: EMEA growth accelerated to 15%; Americas +14%; APAC surged 23% (close to 30% ex-Australia), underpinned by over 50% growth in China.
The company returned EUR 230 million to shareholders through share repurchases and refinanced debt with improved terms, lowering borrowing costs.

View recap

Brookfield Corporation Class A Limited Voting Shares

BN Q2 2026

Reported: 2026-08-15

Brookfield’s shares declined 1.9% post-earnings as investors apparently digested cautious commentary on near-term market noise and geopolitical uncertainties, despite steady capital deployment and strategic initiatives. The market reaction suggests concerns around the uncertain macro environment and lack of explicit upside surprises.

Key takeaways

Distributable earnings before realizations rose 15% year-over-year to $1.4 billion for the quarter.
Capital activity remained robust with $98 billion raised, $100 billion deployed, and $40 billion of assets monetized in the first half.
Strategic expansions included growing the insurance business to $190 billion in assets via the Just acquisition and completing the Oaktree credit platform acquisition.
Management emphasized ongoing geopolitical risks, inflation uncertainties, and energy price pressures, highlighting a constructive but uncertain market backdrop.
The company is positioning itself to capitalize on long-term themes like AI infrastructure, decarbonization, and digitalization, notably with a $100 billion AI campus project backed by the US Department of Energy.

View recap

Borr Drilling Limited

BORR Q2 2026

Reported: 2026-08-15

Shares fell 5.2% as investors reacted negatively to the clear deceleration in EBITDA driven by higher costs associated with Odin’s delayed contract start, rig transition disruptions, escalating operating expenses in a volatile geopolitical environment, and a material credit loss provision.

Key takeaways

Adjusted EBITDA declined sharply by $44.7 million sequentially to $43.8 million, pressured by $22.5 million in Odin-related operating expenses before revenue generation.
Six rigs transitioned between contracts, reducing utilization and revenue recognition during the quarter; this elevated transition activity is now largely resolved.
Operating expenses jumped $31.1 million quarter-over-quarter, including $7.3 million in increased insurance and fuel costs linked to Middle East conflict and contract transitions.
A $10.8 million credit loss on a former West African customer was recognized, fully provisioning receivables from this counterparty.
Despite the challenges, the company expects Q3 EBITDA to improve significantly as rig utilization stabilizes and Odin commences contracted operations.

View recap

Cineverse Corp. Class A Common Stock

CNVS Q1 2027

Reported: 2026-08-15

Cineverse shares fell 7.2% after the quarter as investors reacted negatively to significant margin compression driven by low-margin advertising technology revenue and cautious outlook around margin improvement despite strong revenue growth.

Key takeaways

Revenues surged 175% year-over-year to $30.6 million, boosted by recent acquisitions and new ad tech/media services.
Adjusted EBITDA improved by $2.6 million, marking the second consecutive positive quarter.
Direct operating margin collapsed to 35% from 57% a year ago due to a high revenue share expense (79%) on the new ad tech business.
Management highlighted $13 million in targeted annual cost synergies and a $1.8 million reduction in force underway to improve margins.
No new wide release theatrical films this seasonally slow quarter, with three higher-profile releases expected in the stronger second half of fiscal 27.

View recap

Co-Diagnostics, Inc.

CODX Q2 2026

Reported: 2026-08-15

Shares declined 5.4% following the quarter as investors reacted to a cautious outlook and ongoing execution risks related to regulatory milestones and commercialization timing, signaling disappointment in the pace of revenue growth and near-term visibility.

Key takeaways

The company is transitioning from platform development to commercialization, focusing heavily on regulatory submissions and clinical validations rather than revenue generation.
Key milestone reached with submission of dual 510(k) and CLIA-waived applications for the Flu A/B and RSV assay to the FDA, but no clarity on regulatory timeline or approval risks remains.
Progress on tuberculosis diagnostics in India continues with clinical studies underway, targeting regulatory submissions later this year, though commercialization timing is uncertain.
Investments in scientific leadership were made to strengthen regulatory capabilities, reflecting ongoing challenges in navigating complex approval processes.
Management emphasized long-term strategy execution and scalability ambitions; however, no explicit guidance update or revenue acceleration was provided to offset near-term uncertainties.

View recap

DLocal Limited Class A Common Shares

DLO Q2 2026

Reported: 2026-08-15

Shares declined 0.8% following the quarter as investors likely digested the cautious outlook and the expectation of decelerating growth given the company’s comments about increasingly difficult comparisons ahead and front-loaded investments weighing on cost structure improvements.

Key takeaways

Total Payment Volume (TPV) grew 92% year-over-year to $17.7 billion, marking the highest growth rate since early 2022.
Net revenue retention remained elevated at 153%, continuing a strong trend of merchant relationship depth.
Gross profit increased 29% year-over-year to $127 million, achieving an annualized run rate exceeding $500 million.
Operating profit margin improved by 6 percentage points quarter-over-quarter to 50%, with further operating leverage expected in H2 as AI and automation investments begin delivering cost benefits.
Management highlighted challenges ahead due to tougher comps and ongoing investments, underscoring a cautious outlook on near-term growth dynamics.

View recap

Orsted A/S

DNNGY Q2 2026

Reported: 2026-08-15

Ørsted’s shares declined 6.3% after earnings, reflecting investor disappointment with cautious near-term guidance and margin pressures despite progress on project execution and an optimistic long-term sector outlook.

Key takeaways

Reported EBITDA (excluding partnerships and cancellation fees) was DKK 15 billion, up from the prior year driven by higher offshore generation and wind speeds.
Progress continues on the 8.1 GW offshore wind construction portfolio, with 2.5 GW expected to be commissioned in 2026 as planned.
The company maintains a disciplined capital allocation stance, prioritizing value amid regulatory and geopolitical uncertainty.
Safety performance worsened with a higher injury rate, primarily due to a one-off food poisoning incident, highlighting operational risks.
While long-term prospects for offshore wind remain strong, recent geopolitical tensions and fluctuating energy markets contribute to a cautious near-term outlook, weighing on investor sentiment.

View recap

Ellington Residential Mortgage REIT

EARN Q1 2027

Reported: 2026-08-15

Ellington Credit’s shares edged up 1.1% following a quarter marked by extensive portfolio repositioning and higher earnings capacity, though near-term net investment income has yet to fully reflect these changes. The modest market response appears to reflect tempered confidence that earnings growth will materialize as anticipated, given the lagged impact of second-quarter portfolio moves.

Key takeaways

Reported GAAP net income was $0.33 per share with net investment income of $0.16 per share, modestly impacted by ongoing portfolio transition.
NAV rose to $4.18 per share, achieving an economic return of 8.1% for the quarter.
The CLO portfolio expanded 8.5% to $334.1 million amid active buying and selling, with portfolio rotation focused predominantly within sectors.
Weighted average yields improved, with new purchases yielding ~14.9% and portfolio fair value yield at ~16.6%, supported by tightening credit spreads and loan market fundamentals.
Hedge positions detracted amid tightening credit spreads, offsetting some gains from CLO debt and equity marks and trading activity.

View recap

Eagle Point Credit Company Inc.

ECC Q2 2026

Reported: 2026-08-15

Eagle Point Credit Company's shares edged up modestly by 1.0% after reporting a second quarter marked by recovery in asset valuations and ongoing portfolio repositioning, though the limited market response suggests cautious investor sentiment amid lingering sector uncertainties.

Key takeaways

Net asset value (NAV) increased 8% quarter-over-quarter to $4.51 per share, recovering from first quarter volatility.
GAAP return on common equity was 12.7% for the quarter; cash distributions totaled $0.18 per share.
CLO equity valuations and leveraged loan prices rebounded as market concerns around AI impact on software borrowers and geopolitical issues eased.
Active portfolio management included 8 CLO resets and 7 refinancings, reducing weighted average CLO debt cost by 22 basis points.
Diversification initiatives continued with non-CLO investments rising to 38% of the portfolio from 32%, including successful realization of specialty finance exposure.

View recap

EnerSys

ENS Q1 2027

Reported: 2026-08-15

EnerSys' stock rose 8.9% following Q1 fiscal 2027 results, driven by better-than-expected top-line growth and margin expansion across key segments, particularly in Network & Infrastructure Solutions and Precision Power Solutions, alongside compelling progress in strategic growth initiatives.

Key takeaways

Revenue growth was fueled by favorable price/mix, higher volumes, and disciplined operating expenses.
Network & Infrastructure Solutions and Precision Power Solutions showed strong performance, supported by growth in data center, communications, and defense markets.
Industrial Mobility Solutions showed initial recovery, with material handling demand expected to improve in the latter half of the year.
Strategic progress includes UL and NFPA approvals for the Fortix 172-kilowatt-hour battery energy storage system (BESS), advancing warehouse energy optimization.
Announcement of a DOE grant and a planned U.S.-based lithium manufacturing facility enhances EnerSys’ defense and aerospace market positioning.

View recap

EquipmentShare.com Inc.

EQPT Q2 2026

Reported: 2026-08-15

Shares of EquipmentShare.com Inc. were little changed, declining 0.2% post-earnings as the market appeared cautious despite solid Q2 growth, reflecting concerns around deceleration implied in the updated second-half guidance.

Key takeaways

Q2 rental segment revenue grew 39% year-over-year, driven by accelerated fleet absorption and mega project wins.
Adjusted core EBITDA reached $531 million, supported by mature rental locations generating 55% trailing 12-month margins.
The company expanded its fleet under management to nearly $10 billion of Original Equipment Cost (OEC).
Full-year Rental segment revenue guidance implies 33% growth, but the midpoint suggests a slowdown with 28% growth expected in H2 2026 versus 36% in H2 2025.
Market reaction reflects investor caution on the deceleration and more conservative second-half outlook despite ongoing strong demand and a growing mega project pipeline.

View recap

Euroseas Ltd.

ESEA Q2 2026

Reported: 2026-08-15

Shares declined 0.9% following Euroseas’ Q2 results despite stable fundamentals, reflecting cautious investor sentiment amid no significant positive surprises or guidance updates to drive the stock higher.

Key takeaways

Reported Q2 net revenues of $56.5 million and net income attributable to controlling shareholders of $33.2 million, or $4.74 per diluted share.
Declared quarterly dividend of $0.80 per share, implying a 4.2% to 4.5% yield at current prices.
Continued share repurchase program with 480,000 shares bought back since May 2022, totaling $11.4 million.
Secured multi-year charters at attractive fixed daily rates (~$25,500) extending earnings visibility through early 2028.
Fleet expansion on track with 12 newbuildings ordered for delivery 2027-2029, targeting a modern fleet with ~33 vessels and 97,000 TEU capacity.

View recap

Figure Technology Solutions, Inc. Class A Common Stock

FIGR Q2 2026

Reported: 2026-08-15

Figure’s shares rose modestly by 2.4% following Q2 results that showed continued rapid volume growth and expanding partner traction, though take rate remains under pressure due to channel mix shifts and rising interest rates.

Key takeaways

Consumer loan marketplace volume hit $4.3 billion, up 132% year-over-year and surpassing the top end of guidance by 4%.
Platform partners increased to 489, up 102 from last quarter, with broad growth across independent mortgage banks, servicers, depositories, and fintech SMBs.
Figure Connect represented 65% of marketplace volume, up from 56% last quarter, contributing to strong operating leverage and 55% EBITDA margins.
Take rate declined to 3.6%, near the low end of guidance, pressured by larger partners moving directly to lower-fee Figure Connect, higher interest rates reducing gain-on-sale, and greater first-lien loan volumes.
Management expects take rate headwinds to persist near current low levels in Q3 amid the ongoing shift in business mix.

View recap

Franco-Nevada Corporation

FNV Q2 2026

Reported: 2026-08-15

Shares fell 3.8% as investors reacted negatively to signs of deceleration and cautious outlook around key operations, particularly weaker production at Candelaria and the weighted nature of growth toward the first half of the year. Margin pressures and slower contributions from some assets tempered enthusiasm despite strong commodity prices.

Key takeaways

Total GEOs sold increased 18% year-over-year to 132,405, driven by higher production at Antapaccay, Antamina, South Arturo, and new contributions from recent acquisitions.
Precious metal GEOs rose 23% to 114,111, but production at Candelaria declined due to lower-grade ore compared to last year’s strong Phase 11 output.
Diversified GEOs sold fell slightly to 18,209 despite a 31% revenue increase, reflecting higher gold price assumptions used to convert revenue into GEOs.
Cost of sales increased to $45.9 million from $33.5 million last year, partly due to fixed costs on streamed ounces tied to gold prices.
Depletion expenses rose to $84 million from $64 million, reflecting amortization on recent acquisitions including Yanacocha, Casa Berardi, Porcupine, and Côté.

View recap

FitLife Brands, Inc.

FTLF Q2 2026

Reported: 2026-08-15

FitLife’s shares rose 5.3% following Q2 results, driven by better-than-expected revenue growth and sequential improvement in contribution despite ongoing margin pressure from the Irwin acquisition.

Key takeaways

Total revenue grew 65% year-over-year to $26.5 million, driven primarily by the acquisition of Irwin, with Legacy FitLife revenues declining 23% year-over-year.
Wholesale revenue surged 156% year-over-year to $14.6 million, while online revenue increased 14%.
Gross margin declined materially to 37.0% from 42.8% a year ago, weighed down by Irwin’s lower-margin profile.
Contribution increased 46% driven by Irwin’s addition, but Legacy FitLife contribution fell nearly 26% year-over-year; contribution margin compressed to 34.1% for Legacy FitLife.
Sequentially, total revenue grew 4.8%, with improved stability in Legacy FitLife revenues and ongoing supply chain progress at Irwin reducing out-of-stock losses by over 50%.

View recap

Gambling.com Group Limited Ordinary Shares

GAMB Q2 2026

Reported: 2026-08-15

Shares of Grandstand Limited edged up modestly by 0.5% following Q2 results that were broadly in line with expectations, with revenue and EBITDA steady but marketing segment showing continued pressure. Investors appeared cautious given the ongoing marketing revenue decline offset by cost restructuring and a stable outlook.

Key takeaways

Q2 revenue totaled $37.8 million, adjusted EBITDA reached $7.7 million, both consistent with company guidance.
Adjusted free cash flow was nearly $10 million, indicating solid cash generation despite segment headwinds.
Sports Data Services revenue grew 12% year-over-year, driven by strong B2B growth, particularly from Optic OS, with B2B now the majority contributor and expected to grow over 50% annually.
Marketing revenue declined 10% year-over-year to $26.5 million, primarily due to shrinking SEO revenue, though growth in North America and partner audience monetization partially offset this.
Company restructuring has largely concluded, with cost savings expected to boost margins in H2 and into 2027, supporting the reiterated full-year guidance.

View recap

GDS Holdings Limited

GDS Q2 2026

Reported: 2026-08-15

GDS shares rose 5.1% following the quarter as bookings and reservations significantly outpaced prior levels, supporting a raised full-year sales target and an upwardly revised revenue and EBITDA outlook.

Key takeaways

New bookings reached 260 megawatts in 2Q26, totaling a record 470 megawatts for the first half of the year.
Full-year sales target was increased to 1 gigawatt, driven by strong demand from hyperscale customers and emerging AI leaders.
Reservations added 600 megawatts year-to-date, providing visibility well into 2027 and beyond.
Backlog increased to 757 megawatts mid-year, with booked but not billed adjusted EBITDA estimated at RMB 1.6 billion.
CapEx guidance was raised from RMB 9 billion to RMB 10 billion for 2026 to support accelerated deployment, with financing strategy maintaining approximately 60% debt and 40% equity at the project level.

View recap

Glass House Brands Inc

GLAS Q2 2026

Reported: 2026-08-15

Shares fell 8.6% following Q2 results as investors reacted negatively to a notable revenue miss driven by the removal of retail revenue from consolidated results and margin compression caused by an unfavorable product mix. The cautious margin outlook and operational headwinds in California appear to have weighed heavily on sentiment.

Key takeaways

Reported revenue came in at $47 million, below prior guidance of $55–$60 million, primarily due to the deconsolidation of $10 million in retail revenue.
Gross profit improved sequentially to $15.8 million from $4.1 million in Q1, but gross margin declined sharply to around 34% (implied from commentary), down from 55% in Q2 2025, driven by a higher proportion of low-value trim sales and increased production costs.
Adjusted EBITDA was $5.7 million for the quarter, reflecting ongoing operating leverage despite margin pressure.
The product mix shift to higher trim content, attributed to temporary genetics decisions post-2025 disruption, suppressed margins; management expects a return to more profitable historical genetics going forward.
The company’s exit from retail operations and reliance on challenging California market conditions maintain uncertainty around near-term growth and margin expansion.

View recap

Globant S.A.

GLOB Q2 2026

Reported: 2026-08-15

Shares fell 3.5% as investors reacted to a cautious outlook and signs of revenue deceleration linked to the ongoing transition to outcome-based AI Pod pricing, which is weighing on near-term top-line growth despite margin improvements.

Key takeaways

Revenue reached $614.4 million, up 1.2% sequentially and returning to slight year-over-year growth, though growth remains modest amid transition.
Glob.AI ARR surged roughly 60% quarter-over-quarter to $52.8 million, but accounts for only about 2% of total revenue currently.
AI Pod gross margins run approximately 10 percentage points higher than traditional services, underpinning margin expansion potential.
Revenue per head rose 9.7% year-over-year to a run rate of $95,800, indicating improved productivity as AI adoption advances.
Management is prioritizing accelerating migration to the AI native model, accepting short-term revenue impacts for longer-term margin and value creation.

View recap

G Mining Ventures Corp.

GMIN.TO Q2 2026

Reported: 2026-08-15

The stock closed flat, rising just 0.3% after earnings as G Mining Ventures delivered largely in line operational and financial results, but revised upward full-year cost guidance due to currency effects tempered investor enthusiasm.

Key takeaways

Q2 gold production rose 16% sequentially to 36,845 ounces; sales totaled 37,439 ounces, exceeding plan due to higher grades and stable mill throughput.
Revenue increased 21% year-over-year to $157 million, driven by a record realized gold price of $4,197/oz.
Free cash flow doubled sequentially to $85 million, equating to approximately $2,300 per ounce produced.
Full-year cash cost and all-in sustaining cost (AISC) guidance was raised to $836–$965/oz and $1,330–$1,544/oz respectively, primarily reflecting a stronger Brazilian real.
Significant ongoing investment in Oko West continues, with $153 million spent in the quarter and total commitments at 65% of the initial approved capital budget.

View recap

ESS Tech Inc. Common Stock

GWH Q2 2026

Reported: 2026-08-15

ESS Tech’s shares declined 1.8% following the quarter as investors remained cautious despite ramping sodium-ion opportunities, reflecting tempered confidence amid early-stage commercialization and ongoing execution risks.

Key takeaways

The company is accelerating sodium-ion battery system development in response to strong early demand, with identified opportunities nearing $1 billion.
Signed a letter of intent with Alsym Energy to secure 8.5 gigawatt hours of U.S.-made sodium-ion cells, expanding capacity for short- and medium-duration applications.
Launched the Bridge system, a 1.2-megawatt hour modular sodium-ion battery targeting data centers, critical infrastructure, and utilities.
The underlying iron flow technology continues to support long-duration storage needs, addressing applications unsuitable for lithium-ion solutions.
Despite progress, the business remains in early commercialization stages with inherent operational and financial risks, including control over costs and project execution.

View recap

Intellicheck, Inc.

IDN Q2 2026

Reported: 2026-08-15

Intellicheck's shares plunged 24% following the announcement as investors soured on the cautious outlook amid ongoing customer concentration risks and signaling of volume reductions tied to a key account’s vendor review. The market notably penalized the uncertainty regarding transaction levels with their largest customer and the potential for further deceleration.

Key takeaways

A single customer accounted for approximately 29% of revenue in H1 2026, currently evaluating a multi-vendor approach that may reduce Intellicheck’s transaction volumes.
Management indicated the volume reduction has not yet materialized to the extent initially suggested but acknowledged this evaluation introduces ongoing risk.
Q2 revenue grew 7% year-over-year and sequentially, reflecting diversification efforts and new client additions, primarily in banking and lending.
Retail revenue declined about 2% year-over-year amid persistent macroeconomic headwinds affecting this and other verticals such as automotive and title insurance.
Gross margin remained high at 91%, and adjusted EBITDA was positive for the fifth consecutive quarter, though margin sustainability could be challenged if volume declines intensify.

View recap

MiNK Therapeutics Inc. Common Stock

INKT Q2 2026

Reported: 2026-08-15

Shares declined 0.8% following Q2 results as investors weighed early clinical progress against limited commercial traction and cautious near-term catalysts.

Key takeaways

Initiated randomized Phase 2 study of agenT-797 in acute lung injury and ARDS patients in Ukraine under challenging conditions.
Early non-comparative data showed patients alive and fever-free at day 28 with signs of improved oxygenation and inflammation markers; however, data remain preliminary and require validation in ongoing randomized trial.
No serious adverse events attributed to agenT-797, supporting initial safety profile.
Launched first international named patient access program in Brazil, creating a paid, physician-directed pathway outside of clinical studies, but this is not a commercial launch.
U.S. site activations for the Phase 2 trial are underway with additional clinical data expected in early 2027, leaving near-term inflection points limited.

View recap

JD.com, Inc.

JD Q2 2026

Reported: 2026-08-15

JD.com’s shares dropped 8.1% after earnings as investors reacted negatively to a cautious outlook and signs of deceleration in consumer electronics revenue, despite margin improvements and reduced losses in new businesses.

Key takeaways

JD Retail’s electronics and home appliances revenue moderated due to a high comparison base and upstream price pressures, with momentum only picking up late in the quarter.
Gross margin for JD Retail expanded 1.3 percentage points year-on-year to 18.5%, driven by supply chain scale and higher-margin marketplace revenues.
Operating margin in JD Retail reached a record 4.6% for a peak promotional quarter, reflecting disciplined, ROI-focused marketing spend.
JD Food Delivery narrowed losses by over 50% year-on-year while maintaining healthy order momentum, contributing to significant improvement in unit economics.
Management highlighted a cautious outlook for Q3, expecting JD Retail’s top-line growth to reaccelerate as the trade-in program’s high comparison base fades, indicating near-term pressure on revenue growth.

View recap

Jones Soda Co.

JSDA Q2 2026

Reported: 2026-08-15

Shares declined modestly (-0.7%) as investors seemed unconvinced by the outlook, despite solid top-line growth; the cautious tone on execution challenges and limited details on margin progress tempered enthusiasm.

Key takeaways

Revenue doubled to $10.2 million in Q2, continuing strong growth momentum.
Full-year revenue growth guidance was raised from 60% to ~80%, reflecting confidence in ongoing top-line expansion.
Introduced first full-year adjusted EBITDA guidance, targeting positive profitability for fiscal 2026.
Growth is fueled by core craft soda and expanding branded collaborations, notably a new partnership with Rap Snacks expected to contribute starting fiscal 2027.
Management acknowledged ongoing challenges in two unspecified areas that underperformed expectations, signaling execution risks remain.

View recap

Knightscope Inc. Class A Common Stock

KSCP Q2 2026

Reported: 2026-08-15

Shares gained 8.0% as the quarter's revenue growth and margin expansion outpaced concerns around operating losses and elevated expenses, reflecting investor optimism in the company’s accelerating scale and integration progress.

Key takeaways

Revenue surged 228% year-over-year to $9.0 million, setting a new quarterly record driven by the Security Force acquisition and core subscription growth.
Gross margin improved to 7%, up from a significant gross loss in the prior year, marking a second consecutive quarter of positive margins.
Operating expenses more than doubled to $13.8 million, fueled by increased R&D investment and expanded headcount during integration.
Net loss widened to $14.1 million ($0.79 per share), reflecting higher operating expenses and approximately $1 million in contingent consideration charges.
Progress on next-generation products continued with the K7 autonomous security robot entering beta and partnerships advancing AI and digital twin technologies, supporting market confidence.

View recap

Kuros Biosciences AG

KURN.SW Q2 2026

Reported: 2026-08-15

Shares declined 4.8% following Kuros Biosciences’ half year results as investors reacted negatively to signs of deceleration in key growth metrics and caution on near-term profitability despite the company’s narrative of progress.

Key takeaways

Total medical device sales reached $92.4 million, up 45% year-over-year, reflecting ongoing adoption but with implied slowing acceleration.
Adjusted EBITDA margin stood at 13.6%, generating $12.5 million in adjusted EBITDA and $4.4 million in net profit, pointing to emerging but modest profitability.
Commercial expansion efforts increased distributor reach by 34% and broadened surgeon adoption, yet market share gains may be less transformative than portrayed, raising questions on sustainability.
Management highlighted ongoing evidence generation through clinical trials and operational investments, but the current outlook remains cautious without a stronger margin inflection or clearer visibility on long-term growth cadence.
Upcoming manufacturing capacity expansions scheduled in the US and Netherlands could support future growth but add near-term cost and execution risk.

View recap

Liquidia Corporation

LQDA Q2 2026

Reported: 2026-08-15

Liquidia's stock fell sharply by 18.1% as investors reacted negatively to cautious guidance and anticipated margin pressure amid accelerating R&D and SG&A spending. Despite strong sales growth in YUTREPIA, concerns about escalating expenses and a slower-than-expected profitability trajectory weighed on sentiment.

Key takeaways

YUTREPIA net product sales reached $170.4 million in Q2 2026, up 31% sequentially, continuing a strong growth trajectory since launch.
Net income rose to approximately $74.7 million and adjusted EBITDA to $96.3 million, reflecting improving operating leverage.
Cash balance increased to $284.2 million, up $61.4 million from Q1 due to strong cash flow generation.
R&D and SG&A expenses both increased this quarter driven by pipeline investments and expansion of the commercial sales team, with R&D expected to double in H2 2026 and rise further in 2027.
Management emphasized ongoing and planned clinical trials (10 studies over next 12 months), indicating a clear ramp in development spending that could pressure margins going forward.

View recap

Madison Square Garden Sports Corp.

MSGS Q4 2026

Reported: 2026-08-15

Shares declined 1.7% following earnings, reflecting investor caution despite the Knicks’ championship momentum, as the company’s outlook and financial progress lacked clear catalysts to drive upside.

Key takeaways

Full-year revenues reached approximately $1.15 billion, with adjusted operating income near $58.7 million.
The Knicks delivered record-setting per-game gate revenues during playoffs and highest-ever single day merchandise sales post-championship.
Combined social media following for Knicks and Rangers rose to nearly 22 million, reflecting strong fan engagement.
No season ticket price increase was implemented for the Rangers due to playoff absence; Knicks season ticket prices were increased.
The company advanced its planned spin-off of the Rangers business, targeting completion by October, aimed at unlocking strategic value.

View recap

Nu Holdings Ltd. Class A Ordinary Shares

NU Q2 2026

Reported: 2026-08-15

The 12.3% market rally reflects solid monetization gains and deepening customer engagement, driven by Nubank’s expanding customer base and new product launches, which outweighed any lingering uncertainties on near-term growth and competitive pressures.

Key takeaways

Nubank surpassed $1 billion in net income for the first time, marking a significant earnings milestone.
Customer base reached 139 million, including 118 million in Brazil and 16 million in Mexico following recent banking license approval.
Activity rate expanded to 83.5% overall, with Brazil exceeding 86%, indicating stronger engagement.
Average revenue per active customer (ARPAC) hit $17, contributing to $5.9 billion in gross revenue.
Operating efficiency remained robust with a 20% efficiency ratio, supporting ongoing investment in Brazil, Mexico, and Colombia.

View recap

Ondas Holdings Inc.

ONDS Q2 2026

Reported: 2026-08-15

Ondas shares dropped 5.4% following the earnings release as investors reacted negatively to elevated operating expenses, signaling margin pressure despite strong revenue growth and backlog expansion.

Key takeaways

Second quarter revenue surged to $83.8 million, reflecting more than 13-fold growth year-over-year.
Pro forma backlog expanded over 11x in 2026, now totaling approximately $757 million.
New orders of $105 million captured quarter-to-date, supporting robust commercial momentum.
Cash operating expenses increased substantially, with $29 million spent on growth investments across various corporate initiatives.
The company ended June with $1.4 billion in liquidity but acknowledged elevated OpEx ahead of expected future revenue and gross profit ramps.

View recap

PAN AMERICAN SILVER CORP

PAAS Q2 2026

Reported: 2026-08-15

Shares dropped 9.5% as investors reacted negatively to the downward revision in near-term gold production guidance, driven by operational challenges and more cautious sequencing at key mines Jacobina and El Peñón.

Key takeaways

Q2 attributable silver production was strong at 6.5 million ounces, near the high end of guidance, supporting full-year silver production outlook of 25-27 million ounces.
Gold production came in below quarterly expectations at approximately 166,000 ounces, with Q2 flagged as the weakest gold quarter of 2026.
Full-year gold production guidance reaffirmed but now expected at the low end of 700,000-750,000 ounces, reflecting a revision downward by 3,000 to 6,000 ounces for Q3.
Operational challenges at Jacobina include mining sequencing changes and seismicity risk mitigation, reducing grades and production; gold output at Jacobina expected to be ~10,000 ounces below original guidance.
El Peñón gold production also adjusted down by ~10,000 ounces due to structural continuity issues; silver production remains on target.

View recap

Peyto Exploration & Development Corp.

PEY.TO Q2 2026

Reported: 2026-08-15

Peyto's shares fell 3.4% after earnings as investors reacted negatively to signs of operational deceleration and cautious near-term production activity despite stable margins and continued financial discipline.

Key takeaways

Q2 drilling slowed significantly due to seasonal weather, with only 10 wells spud and capital spending limited to $68 million on well-related activities.
Production was maintained largely by previous quarter drilling, but the slower activity suggests potential near-term output pressure.
Operating margin remained steady at 71%, supported by disciplined cost control and strong realized gas prices, including diversification benefits and hedges.
The company increased its dividend by 9% in May and reduced net debt by $72 million, reflecting ongoing financial prudence.
Guidance remains unchanged with 70-80 wells planned for 2026 and $450-$500 million in capital spending, but execution risks are rising given the slower start and weather challenges.

View recap

Paysafe Limited

PSFE Q2 2026

Reported: 2026-08-15

Paysafe's shares dropped 3.3% following the quarter as investors reacted negatively to margin compression driven by higher marketing and IT spending, despite modest revenue growth. The cautious outlook on sustained profitability and ongoing legal-related expenses likely weighed on sentiment.

Key takeaways

Q2 revenue increased 4% year-over-year to $447.4 million, supported by $12.5 million in licensing data deal contributions.
Adjusted EBITDA declined 2% to $102.8 million, with margins compressing to 23% from 24.5% due to $7 million incremental marketing and IT investments in Q2.
The company reported a 44% adjusted EBITDA to unlevered free cash flow conversion for Q2, generating $45 million, noting typical seasonal cash flow softness and timing issues.
Legal and restructuring costs remain a headwind, including a $39 million expected cash settlement in H2 and $57 million of prior restructuring expenses related to indemnification liabilities.
Management emphasized focus on leverage reduction and consistent growth but the increased investment spending and legacy legal costs appear to have tempered investor enthusiasm.

View recap

Quantum-Si Incorporated Class A Common Stock

QSI Q2 2026

Reported: 2026-08-15

Quantum-Si’s shares dropped 11.7% following the earnings release as the company delayed the Proteus instrument launch by about six months, citing a need for an additional integrated design cycle to reduce execution risk. Investors reacted negatively to the increased timeline, cautious outlook, and margin pressure from associated cost-cutting measures.

Key takeaways

Proteus launch timeline postponed from end of 2026 to Q2 2027, adding an extra integrated instrument design cycle.
Management initiated operating expense reductions to cut cash burn and align costs with the delayed product timeline, impacting near-term margin outlook.
Proteus technology remains fundamentally sound based on sequencing data, but management chose to prioritize derisking the product to ensure readiness and customer experience at launch.
Shift in Library Preparation strategy from a single generic kit to multiple application-specific kits aims to reduce technical risk and accelerate capability delivery at scale.
While progress continues in recognizing amino acids (17 detected so far), the delay allows more time to advance to detecting 19–20 amino acids before launch.

View recap

Rubicon Organics Inc.

ROMJ.V Q2 2026

Reported: 2026-08-15

Rubicon Organics shares dropped 8.0% following the earnings release as investors reacted negatively to cautious outlook commentary and ongoing margin pressure despite notable revenue growth.

Key takeaways

Q2 revenue hit a record $18.5 million, up 23% year-over-year and 35% sequentially, driven primarily by yield improvements at the Pacifica facility and initial revenue from Cascadia.
Gross margin before fair value adjustments was 30%, or 36% excluding pre-revenue Cascadia costs; margin expansion remains a work in progress amid ongoing investments.
Adjusted EBITDA stayed positive at $1.1 million but declined year-over-year, reflecting higher SG&A costs supporting brand development and international expansion.
Cascadia contributed $450 thousand in revenue late in Q2, with yield optimization continuing as a key focus for future quarters.
Management signaled expectations for revenue and EBITDA to ramp in H2 2026 but highlighted ongoing investments and margin pressure, dampening near-term optimism.

View recap

Riskified Ltd.

RSKD Q2 2026

Reported: 2026-08-15

Riskified’s shares surged 22.4% post-earnings, reflecting strong revenue growth and adjusted EBITDA expansion that clearly outpaced cautious market expectations amid a challenging fraud environment.

Key takeaways

Revenue increased 22% year-over-year to $98.7 million, marking the best growth in over four years.
Non-GAAP gross profit rose 13% to $45.4 million, showing solid margin progress.
Adjusted EBITDA jumped 84% to $3.9 million, indicating improved operational leverage.
Processed ACH transaction volume grew roughly 19x year-over-year, highlighting success in expanding non-card payment coverage.
Multiproduct merchant base increased approximately 50% year-over-year, supporting the platform’s expanding footprint and upsell potential.

View recap

RWE Aktiengesellschaft

RWE.DE Q2 2026

Reported: 2026-08-15

RWE shares rose modestly by 2.2% following H1 2026 results that showed good operational progress and an increased EPS guidance, but the market reaction suggests tempered enthusiasm amid a cautious outlook on medium-term returns and capital deployment pace.

Key takeaways

Adjusted EPS grew over 60% year-over-year to EUR 1.8 in H1 2026, supported by strong segment performance and compensation in the Netherlands.
The company raised full-year EPS guidance to EUR 2.95 (from EUR 2.55) and set 2027 guidance at EUR 3.15, reflecting the Amprion stake and improved power generation margins.
Strategic acquisition of a 55% controlling stake in German TSO Amprion adds regulated grid infrastructure as a core pillar, completed at a conservative EV-to-RAB multiple of 1.07x.
Robust project pipeline includes 10.3 GW under construction and a focus on flexible gas generation; FIDs since 2025 average a 9.9% IRR, slightly above their 8.5% target.
The company plans EUR 42 billion net investment through 2031, targeting a 10% EPS CAGR and 10% dividend growth, but the market reaction reflects vigilance around execution risks and the size of capex commitments.

View recap

K+S Aktiengesellschaft

SDF.DE Q2 2026

Reported: 2026-08-15

K+S shares declined modestly (-0.4%) as the market digested a mixed quarter marked by solid Q2 EBITDA performance but limited free cash flow improvement and ongoing operational risks from water scarcity at key sites.

Key takeaways

Q2 EBITDA reached approximately EUR 176 million, up from the prior year, driven by higher selling prices, volumes, and cost discipline despite inflationary pressures.
Free cash flow improved to EUR 40 million but lagged EBITDA growth due to increased working capital tied up in receivables.
The full-year EBITDA guidance was raised to a range of EUR 680 million to EUR 760 million, reflecting a timing shift of maintenance activities from Q2 last year to Q3 this year.
Management expects potash demand in Brazil to remain normal in H2 but acknowledged some uncertainty regarding changes to fertilizer blends influenced by phosphate availability.
Operational risks remain from low water levels affecting cooling processes at the Werra site, although mitigations are in place and prior production shutdowns were linked to 2018, not the 2022 drought.

View recap

Sagicor Financial Company Ltd.

SFC.TO Q2 2026

Reported: 2026-08-15

Sagicor’s shares dropped 3.6% following disappointing core earnings in the legacy life block and margin pressure despite steady new business; cautious investor sentiment appears driven by deceleration in key insurance experience and the impact of reinsurance contract modifications on premium growth.

Key takeaways

Core earnings to shareholders rose to $34 million in Q2, up from $25 million in Q1, helped by improved insurance experience and investment portfolio performance.
Legacy life block insurance experience losses weighed on Sagicor Life USA’s core earnings, dropping to $6 million and dragging overall segment profitability.
Net CSM declined 7% quarter-over-quarter at Sagicor Life due to reinsurance contract changes offsetting organic growth.
Sagicor Canada and Jamaica produced solid new business and investment returns but currency headwinds reduced reported net CSM.
The company remains well capitalized with LICAT ratio at 134% and maintained dividend payments, but cautious market reaction suggests skepticism about sustainability of margin gains and legacy block performance.

View recap

Sky Harbour Group Corporation

SKYH Q2 2026

Reported: 2026-08-15

Shares declined 1.9% following Sky Harbour’s Q2 report as investors digested continuing margin pressures and uneven leasing progress, particularly slow occupancy ramp at Denver Centennial Phase 1, signaling ongoing challenges despite revenue growth.

Key takeaways

Consolidated assets under construction and completed stood at $393 million, up $65 million year-to-date, marking an acceleration in new campus investments.
Q2 revenues increased 50% year-over-year and 13% sequentially, driven by new campus openings and higher occupancy and rental rates.
Operating expenses rose alongside expansion, notably impacted by non-cash accruals for new ground leases on unconstructed campuses.
Adjusted EBITDA improved but remained negative at approximately -$0.9 million, reflecting continuing operating losses offset by flat expenses at active campuses.
Leasing progress remains uneven, with notably slow economic occupancy at Denver Centennial Phase 1, contrasting with stronger cash flow development in Miami and Nashville campuses.

View recap

Southland Holdings Inc. Common Stock

SLND Q2 2026

Reported: 2026-08-15

Southland's shares plunged 16.6% after the company reported a substantial gross loss driven by large noncash legacy dispute adjustments and signaled ongoing challenges in resolving these issues, undermining confidence despite ongoing surety backing. The large legacy dispute-related losses and cautious tone on resolution timelines appear to have driven the sharp stock sell-off.

Key takeaways

Q2 revenue included a $102 million noncash reversal from legacy dispute adjustments, heavily distorting underlying performance.
Gross loss reached $71 million, primarily reflecting a $94 million adverse impact from unresolved legacy disputes.
Legacy backlog continues to shrink but remains significant at $81 million combined across material/paving and non-M&T segments.
Surety partners advanced $71 million during the quarter, with total surety advances at $210 million, indicating continued reliance on external support.
Amendments to capital structure provide liquidity relief, including suspension of scheduled principal payments and fixed 4% interest capitalization through the senior credit facility.

View recap

Soluna Holdings Inc. Common Stock

SLNH Q2 2026

Reported: 2026-08-15

Shares declined 3.0% as investors reacted to signs of margin pressure and a cautious outlook amid significant capital raises and integration costs related to renewable asset acquisitions.

Key takeaways

Revenue grew 145% year-over-year, driven by hosting services for Bitcoin miners and expansion of data center capacity.
Capacity under management reached 192 megawatts, with an increase to 206 megawatts expected this summer.
Company completed key acquisitions including full ownership of Project Dorothy 1 and the 150-megawatt Briscoe Wind Farm, shifting towards asset ownership to control power supply.
Raised $159.4 million in Q2 and additional $23.6 million post-quarter through equity issuance, resulting in dilution but enabling asset consolidation and debt retirement.
Introduced new revenue streams including grid ancillary services and on-site wind generation, but profitability and margin outlooks remain cautious amid continuing capital intensity.

View recap

Similarweb Ltd.

SMWB Q2 2026

Reported: 2026-08-15

Shares jumped 24.3% following Q2 results that beat revenue and operating profit expectations, driven by record net new ARR, improved retention, and large multiyear enterprise contracts anchored by growing AI demand.

Key takeaways

Revenue rose 9% year-over-year to $77.2 million, exceeding the top end of guidance.
Positive GAAP operating profit delivered for the first time, alongside non-GAAP operating profit above expectations.
Net new annual recurring revenue (ARR) hit a company record, with net revenue retention (NRR) of 100% overall and 107% for customers above $100,000 ARR.
AI-related revenue increased to 13% of total revenue, supporting expansion into a growing AI-driven market.
Signed 3 large multiyear enterprise contracts totaling over $60 million in contract value, signaling success in moving upmarket and deepening enterprise penetration.

View recap

Spire Global, Inc.

SPIR Q2 2026

Reported: 2026-08-15

Shares of Spire Global fell 5.9% following the earnings release, reflecting investor disappointment with cautious commentary on contract timing and the absence of an upgraded full-year outlook despite sequential revenue growth and contract progress.

Key takeaways

Q2 revenue reached $18 million, with core revenue up sequentially and year-over-year excluding the divested maritime business.
The company reaffirmed full-year revenue guidance targeting 50% core revenue growth despite no upward revision.
Progress reported on NOAA contract negotiations, including an 8-figure opportunity and an extension valued at up to $5 million; however, timeline uncertainty persists due to evolving government IDIQ contract structures.
RF geolocation bookings expanded with awards from four new international customers in Q2, supporting a multi-year growth runway, but most remain in early pilot or subscription phases.
Satellite capacity increased, with 29 satellites launched in 2026 and advanced single satellite geolocation capabilities enhancing coverage and efficiency.

View recap

Stratasys Ltd.

SSYS Q2 2026

Reported: 2026-08-15

Stratasys shares edged up modestly (+1.8%) after reporting generally stable results, driven by sustained growth in consumables and aerospace & defense segments, though the market appeared cautious on broader outlook or margin expansion.

Key takeaways

Total revenue rose 3.7% sequentially, supported by record consumables sales that reflect high system utilization.
Aerospace & Defense remains the largest business unit, growing 17% year-over-year, fueled by expanding U.S. Air Force adoption and ongoing multi-system orders for flightworthy production parts.
Stratasys Direct parts manufacturing grew 12.1% year-over-year, with demand driven by defense-related drone production and munitions applications.
The company continues to focus on operational discipline and cost management, though no concrete margin improvement details were highlighted.
Pending acquisition of MarkForged aims to enhance production capabilities, particularly in aerospace and industrial verticals, signaling strategic expansion but not yet reflected in results.

View recap

Stantec Inc.

STN Q2 2026

Reported: 2026-08-15

Stantec’s shares declined modestly by 0.7% following Q2 results that showed steady top-line growth and margin expansion, but investors appeared cautious given flat organic growth in the U.S. segment and a moderate outlook on project ramp-ups.

Key takeaways

Net revenue increased 11.5% year-over-year to $1.8 billion, driven by 3.7% organic and 7.1% acquisition growth.
Adjusted EBITDA margin expanded by 90 basis points to 18.7%, reaching a Q2 record, supported by disciplined cost management.
Adjusted EPS rose 18.4% to $1.61 due to revenue growth and margin improvement.
Organic growth was flat in the U.S. segment due to project delays and slower ramp-up, though management expects acceleration later in the year.
Contract backlog reached a record $9.2 billion; however, cautious commentary on project timing likely tempered investor enthusiasm despite solid medium-term prospects.

View recap

Swarmer, Inc Common Stock

SWMR Q2 2026

Reported: 2026-08-15

Swarmer shares rose 4.9% after earnings, reflecting investor approval of the $1 million contract expansion with SkyKnight and progress in strategic partnerships that enhance its autonomous systems platform.

Key takeaways

Added approximately $1 million in contracted license value to the SkyKnight program; total potential contract value up to $14.2 million if all options are exercised.
Received $1.4 million in cash for SkyKnight licenses during the quarter, though some revenue was deferred due to accounting rules.
Highlighted real-world data advantage, with technology supporting over 100,000 combat missions since April 2024, enhancing AI and autonomy performance.
Advanced ecosystem through partnerships with Oak Grove Technologies, Lantronix, Molfar, and Brightline, expanding platform integration and operational data sources.
Positioned as platform-agnostic software layer targeting wide adoption across air, land, and maritime autonomous systems.

View recap

TMC the metals company Inc.

TMC Q2 2026

Reported: 2026-08-15

The stock fell 10.3% as investors reacted negatively to delays and increasing uncertainty around permitting timelines, pushing back expected permit grants beyond initial forecasts and raising concerns about project execution and cash flow timing.

Key takeaways

NOAA’s certification of the USA-A permit is now expected in October 2026, later than prior expectations, delaying the permit grant beyond Q1 2027.
Delay attributed to administrative issues, not application quality, but risks extend the timeline for vessel commissioning and commercial operations.
The company continues progress on regulatory milestones, including environmental impact statements and public comment periods, but permitting remains a bottleneck.
Engagement with multiple U.S. agencies and partners is aimed at establishing a comprehensive American supply chain, but capital markets activity is on hold pending clearer funding paths.
Market reaction reflects skepticism over timing risks and execution challenges despite ongoing strategic collaborations and technical advancements.

View recap

TSS, Inc.

TSSI Q2 2026

Reported: 2026-08-15

TSS shares plunged 20.1% as investors reacted negatively to a sharp revenue decline driven by a pronounced pullback in low-margin Procurement revenue, overshadowing growth in higher-margin segments. The notable topline deceleration and cautious near-term outlook on Procurement weighed heavily on sentiment.

Key takeaways

Total Q2 revenue declined 20% year-over-year to $35.1 million, primarily due to Procurement revenue falling from $33 million to $18.2 million.
Higher-margin Systems Integration revenue grew 46% year-over-year, now representing 39% of total revenue, up from 22% last year.
Facilities Management posted an 84% increase, bolstering margin expansion efforts.
Consolidated gross profit increased 11% and adjusted EBITDA rose 12%, reflecting better profitability mix despite lower revenue.
Management forecasts Procurement revenue to rebound to $30–40 million in Q3 but acknowledged variability and challenges in timing of large customer orders.

View recap

TUI AG

TUI1.DE Q3 2026

Reported: 2026-08-15

Shares declined 2.6% as investors digested lower-than-expected revenue and EBIT declines driven by geopolitical disruptions, increased costs, and softness in key markets, overshadowing stable margins and progress in transformation initiatives.

Key takeaways

Q3 revenue declined by over 5% year-over-year to roughly €6 billion; 9-month revenue was down 1.5%.
EBIT for Q3 was positive at €86 million but down from last year; 9-month EBIT was €40 million below last year after one-off costs.
Major headwinds included direct one-offs of €60 million related to the Iran conflict (e.g., repatriation of two cruise ships) and €21 million from the Jamaica hurricane.
Cruise and hotel segments showed resilience with stable or improved occupancy and pricing trends, though cruise was impacted by the two ships stuck in the Middle East.
Airline segment losses of €65 million persisted, reflecting challenges in Germany (long-haul decline) despite positive trends in the UK; occupancy remained steady at 91%.

View recap

Treasury Wine Estates Limited

TWE.AX Q4 2026

Reported: 2026-08-15

Shares rose modestly by 1.9% as Treasury Wine Estates delivered results largely in line with expectations, supported by Penfolds' strong depletions growth and margin management, even as margin compression and ongoing transformation-related headwinds temper enthusiasm.

Key takeaways

FY26 EBITS came in at $492 million, slightly ahead of guidance, driven by strong fourth-quarter Penfolds performance.
Statutory NPAT was a loss of $1.1 million due to a $558 million noncash impairment related to U.S. supply chain rebalancing.
NSR per case declined 3%, reflecting portfolio mix and deliberate reductions in parallel imports and inventories, notably in China.
EBITS margin contracted to 19%, impacted by lower NSR and higher operating costs amid transformation efforts.
Penfolds maintained solid depletions growth across China, Asia, and Australia; Treasury Americas saw U.S. depletions return to growth in the second half despite first-half supply disruptions.

View recap

Sembcorp Industries Ltd

U96.SI Q2 2026

Reported: 2026-08-15

Shares declined 1.2% following Sembcorp’s first half 2026 report as weaker renewables earnings and lower spark spreads in the gas segment weighed on investor sentiment despite stable contracted cash flows and the recent Alinta acquisition.

Key takeaways

Underlying net profit was SGD 369 million, with pro forma including Alinta at SGD 558 million; EPS stood at SGD 0.207 (0.314 pro forma).
Gas and Related Services net profit declined to SGD 285 million, pressured by lower spark spreads and the loss of a U.K. industrial customer, partially offset by strong contracted portfolio (80% contracted for 5+ years).
Renewables segment underperformed with net profit of SGD 69 million due to weak wind and solar generation in China, tariff reductions, and removal of VAT refunds.
Integrated Urban Solutions delivered SGD 62 million in net profit, impacted by divestment of SembEnviro but supported by growth in industrial land and water businesses.
Alinta acquisition completed in June; first-half contribution showed strong underlying net profit doubling to SGD 231 million, driven by low-cost generation and long-term gas contracts.

View recap

Zix Corporation

VUZI Q2 2026

Reported: 2026-08-15

Vuzix shares surged 18.3% following the release of their second quarter results, reflecting strong investor enthusiasm around expanding AI-driven enterprise smart glasses opportunities and improving commercialization prospects.

Key takeaways

Vuzix highlighted significant growth potential across three core segments: enterprise smart glasses, OEM products, and waveguides.
AI integration is driving a shift toward optically see-through, self-contained smart glasses preferred by major enterprise and defense customers.
Management emphasized a decrease in software integration barriers, crediting AI for accelerating deployments and lowering costs.
Established clients like Amazon continue to expand use cases, supporting reliability and maintenance functions in automated environments.
The company’s outlook is anchored on broadening production volumes as validation programs approach commercialization, signaling a potential step-change in revenue size and mix.

View recap

Vestas Wind Systems A/S

VWDRY Q2 2026

Reported: 2026-08-15

The market rewarded Vestas with a 17.7% gain following Q2 driven by substantial beats in order intake and revenue growth, coupled with a raised full-year guidance reflecting improved visibility and operational momentum.

Key takeaways

Revenue surged 26% year-over-year to EUR 4.7 billion, fueled primarily by a 37% increase in the Power Solutions segment.
Order intake jumped 67% to 3.3 gigawatts, led by strong onshore demand in the U.S. and Germany; offshore orders were absent in the quarter but management notes lumpiness in that segment.
EBIT margin improved to 9.4%, supported by gains in both onshore and offshore operations, though the company remains 200 basis points shy of its 10% EBIT margin target for the year.
Service backlog expanded by EUR 5 billion year-over-year to EUR 40.9 billion, with 166 gigawatts under active service contracts, reflecting progress in the commercial reset.
A EUR 400 million share buyback program was announced to start immediately and run through December, indicating confidence in capital return despite ongoing operational challenges.

View recap

Workhorse Group Inc.

WKHS Q2 2026

Reported: 2026-08-15

Shares declined 1.0% following Q2 results as investors appeared cautious despite steady progress; no clear catalyst emerged to drive the stock higher amid ongoing transformation and early-stage market adoption challenges.

Key takeaways

Workhorse is transitioning from an electric commercial vehicle manufacturer into a broader industrial technology company, including entry into the nascent mobile AI data center market.
The company reported sequential declines in operating expenses while increasing production, reflecting operating leverage from integration efforts.
Management highlighted ongoing cost reduction initiatives, including supplier negotiations and system consolidations (e.g., Smart Hub), aimed at lowering bill of materials costs.
Despite progress on integration and cost synergies targeting $20 million annually by year-end, broader commercial electric truck adoption remains in early stages with adoption hinging on delivering superior economic value.
No incremental financial details or guidance revisions were provided to materially shift investor sentiment.

View recap

X-Energy, Inc. Class A Common Stock

XE Q2 2026

Reported: 2026-08-15

X-Energy's shares gained 3.1% following the Q2 earnings release, driven primarily by meaningful progress in securing long-term supply contracts and additional government funding that de-risk the fuel supply chain, reassuring investors on near-term project execution.

Key takeaways

The Department of Energy approved up to an additional $1 billion for the ARDP program, bringing total federal funding to approximately $2.1 billion under a 50-50 cost-sharing arrangement.
Long-term HALEU enrichment contracts with Centrus Energy and General Matter were signed, covering initial and replacement fuel needs and reducing a critical supply bottleneck.
An $8 million investment agreement with SGL Carbon aims to double graphite production capacity by 2030, enabling manufacturing for up to eight reactors per year.
Early supply chain investments are being structured to be transferred to customers, aiming to secure capacity and mitigate schedule risks for first commercial deployments.
Despite positive progress on supply and funding, commercial deployment remains years away, underscoring ongoing execution risks inherent at this stage.

View recap

York Space Systems, Inc.

YSS Q2 2026

Reported: 2026-08-15

Shares declined 1.0% following York Space Systems' Q2 results, as the modest stock reaction indicates investor caution despite steady execution and contract momentum, with no clear catalyst to drive the stock higher.

Key takeaways

Revenue rose 10% year-over-year to $92.5 million, supported by ongoing satellite launches and new customer additions.
Backlog remains robust at $592 million, with an identified pipeline exceeding $11.5 billion, reflecting sustained opportunity.
The company secured four new contracts this quarter, maintaining a high 88% win rate on proposals year-to-date.
Recent acquisition of ALL.SPACE expected to contribute 10–15% of 2026 revenue, expanding assured communications and unmanned systems capabilities.
No guidance update or margin commentary provided that might have reassured investors, leaving the stock to reflect steady but unspectacular results.

View recap

Earnings Recaps

CK Hutchison Holdings Limited

JD Logistics, Inc.

CapitaLand Investment Limited

Absci Corporation Common Stock

Applied Materials, Inc.

Alpha and Omega Semiconductor Limited

Apotex Health Corp

Atea Pharmaceuticals, Inc.

Birkenstock Holding plc

Brookfield Corporation Class A Limited Voting Shares

Borr Drilling Limited

Cineverse Corp. Class A Common Stock

Co-Diagnostics, Inc.

DLocal Limited Class A Common Shares

Orsted A/S

Ellington Residential Mortgage REIT

Eagle Point Credit Company Inc.

EnerSys

EquipmentShare.com Inc.

Euroseas Ltd.

Figure Technology Solutions, Inc. Class A Common Stock

Franco-Nevada Corporation

FitLife Brands, Inc.

Gambling.com Group Limited Ordinary Shares

GDS Holdings Limited

Glass House Brands Inc

Globant S.A.

G Mining Ventures Corp.

ESS Tech Inc. Common Stock

Intellicheck, Inc.

MiNK Therapeutics Inc. Common Stock

JD.com, Inc.

Jones Soda Co.

Knightscope Inc. Class A Common Stock

Kuros Biosciences AG

Liquidia Corporation

Madison Square Garden Sports Corp.

Nu Holdings Ltd. Class A Ordinary Shares

Ondas Holdings Inc.

PAN AMERICAN SILVER CORP

Peyto Exploration & Development Corp.

Paysafe Limited

Quantum-Si Incorporated Class A Common Stock

Rubicon Organics Inc.

Riskified Ltd.

RWE Aktiengesellschaft

K+S Aktiengesellschaft

Sagicor Financial Company Ltd.

Sky Harbour Group Corporation

Southland Holdings Inc. Common Stock

Soluna Holdings Inc. Common Stock

Similarweb Ltd.

Spire Global, Inc.

Stratasys Ltd.

Stantec Inc.

Swarmer, Inc Common Stock

TMC the metals company Inc.

TSS, Inc.

TUI AG

Treasury Wine Estates Limited

Sembcorp Industries Ltd

Zix Corporation

Vestas Wind Systems A/S

Workhorse Group Inc.

X-Energy, Inc. Class A Common Stock

York Space Systems, Inc.

Community

Trending This Week

Notifications